OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Condition: Opioid-use Disorder Interventions: Device: OXD01 digital therapy; Other: Standard of Care Sponsor: Orexo AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
Condition: Opioid-use Disorder Intervention: Drug: Buprenorphine/naloxone Sponsor: University of British Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2021 Category: Research Source Type: clinical trials